WATSON 335 (Acyclovir 400 mg)
Pill imprint WATSON 335 has been identified as Acyclovir 400 mg.
Acyclovir is used in the treatment of herpes simplex, suppression; herpes simplex; herpes zoster; herpes simplex, mucocutaneous/immunocompromised host; varicella-zoster (and more), and belongs to the drug class purine nucleosides. There is no proven risk in humans during pregnancy. Acyclovir 400 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 335 (Acyclovir 400 mg)
- Imprint:
-
WATSON 335
- Strength:
- 400 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Purine nucleosides
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0335
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-4765 | A S Medication Solutions LLC (repackager) |
| 54868-3997 | Physicians Total Care Inc (repackager) |
| 55887-0246 | Diversified Healthcare Services Inc (repackager) |
| 13411-0182 | Advanced Pharmaceutical Services Inc (repackager) |
| 63874-0500 | Altura Pharmaceuticals Inc (repackager) |
| 53002-0008 | Pharmedix (repackager) |
Note: Inactive ingredients may vary.
More resources
Acyclovir is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
